HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NARS Defends China Entry, Maintaining Support For 'Cruelty-Free World'

This article was originally published in The Rose Sheet

Executive Summary

"It is important to bring our vision of beauty and artistry to fans in the region," says Shiseido's NARS brand on its decision to launch in China. Like others that have made the same decision, NARS now is working to manage the fallout among cruelty-free intransigents.

You may also be interested in...



The Body Shop Seeks Global End To Animal Testing Through UN Petition

The L'Oreal company and Cruelty Free International are working to drum up 8m signatures on a petition to the UN, with the goal of spurring an international pact banning cosmetic animal testing across UN member states. If a treaty were to emerge, getting the US on board without FDA support – which seems unlikely based on recent remarks from the agency's Linda Katz – could be exceedingly difficult.

Nudestix Launches To China With Cruelty-Free Status Intact; CEO Explains How

The Canadian company’s experience launching to China confirms that foreign and domestic cosmetics brands are competing in the country on a more level playing field these days, with less harm to animals.

China Pilot Program May Let Cosmetic Importers Bypass Animal Testing

While nothing is certain and visibility is low as usual, China may be on the verge of allowing importers of ordinary (non-special use) cosmetics to forgo animal testing otherwise required by the China Food and Drug Administration when they go through the Shanghai Pudong New Area. Reportedly, a pilot program enabling a simplified filing process will kick off in March to test the system under consideration.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel